Sabine Lang

1 Patent

• US125655302026

  Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody

  Hoffmann-la Roche Inc.

  0 cites